Go-to-Market Business Plan for WISHcpd™ Educating Clinicians to Adopt MedTech

Closed
Preferred learners
  • Anywhere
  • Academic experience
Categories
Market research Market expansion Product or service launch Education
Skills
virtual reality child development value propositions revenue stream master of business administration (mba) business planning go-to-market strategy business case artificial intelligence machine learning
Project scope
What is the main goal for this project?

Title: WISHcpd™ - Wearable Insights Smart Health continuing professional development.

INTRODUCTION

The Future Care (UK) Ltdis an SME and is seeking a Go-to-Market Business Plan across the EdTech CPD training market. We are seeking research into the accredited clinical continuing professional development education/training market. EdTech is a large and rapidly growing market.

This research will help position Future Care's WISHcpd™ accredited training program to educate clinicians in the use and adoption of MedTech. The focus will be on one or more countries e.g. UK, Canada, USA, AU, that carry out CPD education in English.

The Go-to-Market business plan will include ALL the elements including not bot limited to; financial business case, value proposition competitors and economics around adoption and necessity, especially post COVID.

FC is seeking a university/post grad(s), MBA/CAPSTONE individual(S) or team(S) to develop this business plan.

As part of the development of the plan, FC is keen to identify channel partners that FC could collaborate with in bringing WISHcpd™ to market.

BACKGROUND

According to FC's research there is no accredited clinical CPD programme that informs clinicians, social services commissioners, and front-line key workers, with a programme that supports them in the power and potential of digital health/medtech, how it can change and improve work practises, patient user outcomes, implantation in their work practise and improve efficiencies. WISHcpd™ fills this knowledge/adoption gap.

WISHcpd™ program is spread across four main modules:

1. Review of new technologies, lifestyle and Medtech in general, direction of travel, APP self-managed therapies and use of data,

2. Expectations, ethical concerns, and manage the clinician’s barriers to adoption.

3. Medtech integration of into clinician’s work practice, diagnostics and sync with their legacy, patient record systems. This module could include a simple virtual reality (VR) option.

4. Database of telecare, digital health/Medtech, product services and therapies. This is not dissimilar to the way a doctor uses a directory of available drugs to address medical symptoms. The end objective of the database will be an approved / accredited, go-to place for integrating digital health and wellness devices into clinical work practises for better patient outcomes. Database of Dhealth & Wellness products, services, and therapies will be driven by Artificial Intelligence (AI) / Machine Learning (ML) and will learn from a user’s engagement, patterns to speed up recommend and inform user of other related initiatives around their interests.

The database is almost a standalone product and revenue stream. This database will need to be developed and populated.

COMMERCIAL POTENTIAL

1. Traditional pay-as-you-go or subscription for single or multi-user eLearning licence

2. Subscription to telecare product resources database

3. Turnkey managed resource(s) for: Pharmaceutical, public, or commercial health provider, association

4. White label and affiliate companies

5. Extension products derived from the foundation of WISHcpd targeting other users.

FYI

FC has a body of resources to support this business plan and from which students can build on.

FC has submitted a separate project addressing the physical development of WISHcpd™ educational programme.

About the company
  • http://futurecareuk.com/
  • 0 - 1 employees
  • Retail, Technology, Education, Hospital, health, wellness & medical, Consumer goods & services

Future Care(FC) is an SME based in London, UK. Our R&D is focused on a bespoke, wearable, non-invasive, medical precision instrument for infants (0-24months), remotely monitoring vital signs and integrated stethoscope, linked to a predictive & preventative analytics platform, Reports and Alarms sent to end user consumer (B2C) and medical (B2M) APPS.
FC works closely with ARROW is a $30B international electronics company and their partners e.g. Microsoft.